Luteolin offers novel therapeutic regimen in rotenone-induced Parkinson disease via modulation of TNF-α/FXMRP/serotonin/tyrosine hydroxylase signaling pathway. NJPS [اینترنت]. 31 دسامبر 2025 [ارجاع شده 14 آوریل 2026];40(2):251-62. قابل دسترس در: https://www.ojshostng.com/index.php/njphysiologicalsciences/article/view/4001